DermaLife forms collaboration with Bioderma – France towards world class dermatological care in Sri Lanka

Thursday, 26 May 2022 02:24 -     - {{hitsCtrl.values.hits}}

Ajantha Vidanarachchi and Shane Silva 

 


DermaLife Ltd., a specialty health-care company dedicated to prescription dermatological and aesthetic skincare recently announced its international collaboration with Bioderma Laboratories, a privately owned French pharmaceutical company specialising in medication for dermatological and hair/scalp conditions, as well as for paediatric and cell regeneration. 

DermaLife was established by pharmaceutical professionals with over 25 years of experience in the industry with a resolve to provide innovative solutions recognised internationally to a niche clientele within the Sri Lankan market seeking best-in-class dermatological care.

Having identified a market gap for high-end dermatological products DermaLife was established to make available treatment and solutions within Sri Lanka that would otherwise require sophistication of overseas health care facilities at considerable cost.  Having secured exclusive representation to some of the world’s leading manufacturers from Europe over the years, DermaLife has partnered with brands including Elcea Laboratories – France, Laboratorio Genove SA – Spain, Noreva Laboratoire Dermatologique – France, Quest Nutrapharma- UK and Dermofarm S.A.U – Spain/Italy.

Its most recent exclusive partnership with Bioderma Laboratorie Dermatoloique, was highlighted as a game changer for the Sri Lankan dermatological landscape by the DermaLife Founder Chairman Ajantha Vidanarachchi who states: “This partnership comes to us at a time that we continue to unravel and understand the science behind regenerative medicine that is becoming more prevalent in the medical field and is highly sought after due to its faster healing and recovery times than traditional methods. 

“The partnership with Bioderma is highly valued by us because it solidifies the faith and confidence that international brands have continued to have in us over the years as their respective exclusive partner in Sri Lanka. Despite economic challengers faced across the industry we have continued to consistently deliver world class skin care ensuring availability even during these challenging times. 

“Our commitment remains unwavering to provide Sri Lankans technologically and scientifically current treatments and solutions by maintaining strong international collaborations with European partners that regard medical and quality certifications at the centre of their brand.”

Bioderma Laboratories is a privately owned French pharmaceutical company that specialises in medication for dermatological and hair/scalp conditions, as well as for paediatric and cell regeneration founded in 1977, in Aix en Provence, where its headquarters still reside. 

In 2001, the company opened its first specialised biometrology lab for skincare research and development in Lyon. Its primary business sector is Dermatology, with products such as ABCDerm, Atoderm, Cicabio, Créaline, Hydrabio, Matriciane, Matricium, Sébium, White Objective, Secure (skin care), Nodé (hair care) and Photoderm (sun care).

Reliving the former successes of the brand, DermaLife fellow Director Shane Silva, recalled that Bioderma is credited worldwide for having created the first micellar water Sensibio H2O in that became a skincare best-seller all around the world with a success rate of one bottle of Sensibio micellar water sold every two seconds in the world.

He continued to add the reason for the company success is being able to secure international collaborations owing to its exceptional growth record over last five years was facilitated by the trust and confidence in the products from experts within the medical fraternity. 

He further stated: “All our products have surpassed extensive research, European quality and medical safety standards and NMRA registrations within Sri Lanka.”

Those interested in learning more about the DermaLife product range were encouraged to visit the company website for more information.

 

COMMENTS